Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 24Other hematologic neoplasm 3Lymphoid 3Genitourinary 3Gastrointestinal 3Sarcoma 2Plasma cell 2Other 2Breast 2Myeloid 1Head & Neck 1Gynecologic 1Classical hematology 1CNS 1

Conditions

Neoplasms 1Anemia, Sickle Cell 1

Interventions

Epoetin Alfa 25Darbepoetin alfa 17apixaban 9Rivaroxaban 9Dalteparin 7Heparin, Low-Molecular-Weight 6Surveys and Questionnaires 5Meropenem 5fludarabine phosphate 4Vancomycin 4Tinzaparin 4Enoxaparin 4Cyclosporine 4Cefepime 4ferric carboxymaltose 3edoxaban 3Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Ceftazidime 3Carboplatin 3Busulfan 3Antilymphocyte Serum 3Amikacin 3romiplostim 2peginesatide 2hematide 2fludarabine 2epoetin beta 2bemiparin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Interviews as Topic × Classical hematology × Clear all
NCT01591187 2015-03-05

The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease

St. Jude Children's Research Hospital

Completed
77 enrolled
Classical hematology

Anemia, Sickle Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡